Haemonetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. 

CEO
Christopher A. Simon
CEOChristopher A. Simon
Employees
3,009
Employees3,009
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1971
Founded1971
Employees
3,009
Employees3,009

HAE Key Statistics

Market cap
5.46B
Market cap5.46B
Price-Earnings ratio
55.53
Price-Earnings ratio55.53
Dividend yield
—
Dividend yield—
Average volume
751.64K
Average volume751.64K
High today
$123.75
High today$123.75
Low today
$116.79
Low today$116.79
Open price
$120.59
Open price$120.59
Volume
799.46K
Volume799.46K
52 Week high
$132.00
52 Week high$132.00
52 Week low
$51.00
52 Week low$51.00

Stock Snapshot

As of today, Haemonetics(HAE) shares are valued at $120.00. The company's market cap stands at 5.46B, with a P/E ratio of 55.53.

On 2026-11-07, Haemonetics(HAE) stock traded between a low of $116.79 and a high of $123.75. Shares are currently priced at $120.00, which is +2.7% above the low and -3.0% below the high.

Haemonetics(HAE) shares are trading with a volume of 799.46K, against a daily average of 751.64K.

In the last year, Haemonetics(HAE) shares hit a 52-week high of $132.00 and a 52-week low of $51.00.

In the last year, Haemonetics(HAE) shares hit a 52-week high of $132.00 and a 52-week low of $51.00.

HAE News

Simply Wall St 16h
Haemonetics Lifted Guidance, Is The Stock Fully Valued?

Haemonetics (HAE) is back in focus after reporting fiscal second quarter results that topped revenue and earnings forecasts, with management also lifting guidan...

Haemonetics Lifted Guidance, Is The Stock Fully Valued?
TipRanks 1d
Haemonetics Earnings Call Highlights Growth and Margin Tradeoffs

Haemonetics ((HAE)) has held its Q2 earnings call. Read on for the main highlights of the call. Haemonetics delivered a strongly positive earnings call, suppor...

Simply Wall St 7d
FDA Clearance Could Be A Game Changer For Haemonetics Stock

Haemonetics reported past FDA approval of its PerQseal Elite vascular closure system in the U.S., adding a bioabsorbable, sutureless option for large bore arter...

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.